ANAPLASTIC ASTROCYTOMA
Clinical trials for ANAPLASTIC ASTROCYTOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC ASTROCYTOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC ASTROCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug ruxolitinib joins standard therapy in brain cancer battle
Disease control CompletedThis early-phase study tested whether adding the experimental drug ruxolitinib to standard radiation and chemotherapy (temozolomide) is safe for people with newly diagnosed high-grade gliomas or glioblastoma. Ruxolitinib targets proteins that help cancer cells grow. The study enr…
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug shows promise in early trial for kids with deadly brain cancer
Disease control CompletedThis early-phase study tested an experimental drug called INCB7839 in 13 children whose high-grade gliomas (aggressive brain tumors) had come back or worsened after standard treatment. The main goals were to find a safe dose and check for side effects. The drug works by blocking …
Matched conditions: ANAPLASTIC ASTROCYTOMA
Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC